MAPT and Alzheimer disease: Activated PARP-1 colocalizes with Aβ, tau and microtubule-associated protein 2 [12] and acts by promoting both the Aβ deposition and the formation of tau tangles that, in turn, aggravate the symptoms of AD [51].